Organovo Holdings Inc (ONVO)
0.40
+0.05
(+14.32%)
USD |
NASDAQ |
Nov 22, 16:00
0.395
0.00 (0.00%)
After-Hours: 20:00
Organovo Holdings Enterprise Value: 2.972M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 2.972M |
| November 21, 2024 | 2.202M |
| November 20, 2024 | 2.204M |
| November 19, 2024 | 2.069M |
| November 18, 2024 | 2.665M |
| November 15, 2024 | 3.247M |
| November 14, 2024 | 2.419M |
| November 13, 2024 | 2.358M |
| November 12, 2024 | 2.379M |
| November 11, 2024 | 2.957M |
| November 08, 2024 | 2.997M |
| November 07, 2024 | 3.433M |
| November 06, 2024 | 3.002M |
| November 05, 2024 | 3.280M |
| November 04, 2024 | 3.633M |
| November 01, 2024 | 3.971M |
| October 31, 2024 | 3.776M |
| October 30, 2024 | 3.776M |
| October 29, 2024 | 3.664M |
| October 28, 2024 | 3.403M |
| October 25, 2024 | 3.616M |
| October 24, 2024 | 4.063M |
| October 23, 2024 | 4.217M |
| October 22, 2024 | 3.910M |
| October 21, 2024 | 3.925M |
| Date | Value |
|---|---|
| October 18, 2024 | 4.048M |
| October 17, 2024 | 3.874M |
| October 16, 2024 | 3.966M |
| October 15, 2024 | 3.472M |
| October 14, 2024 | 3.384M |
| October 11, 2024 | 3.694M |
| October 10, 2024 | 3.628M |
| October 09, 2024 | 3.862M |
| October 08, 2024 | 3.756M |
| October 07, 2024 | 3.742M |
| October 04, 2024 | 3.986M |
| October 03, 2024 | 3.904M |
| October 02, 2024 | 4.125M |
| October 01, 2024 | 4.097M |
| September 30, 2024 | 4.647M |
| September 27, 2024 | 0.9704M |
| September 26, 2024 | 0.554M |
| September 25, 2024 | 0.6124M |
| September 24, 2024 | 1.181M |
| September 23, 2024 | 0.998M |
| September 20, 2024 | 1.440M |
| September 19, 2024 | 1.603M |
| September 18, 2024 | 1.802M |
| September 17, 2024 | 1.818M |
| September 16, 2024 | 1.802M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-13.78M
Minimum
Jun 28 2022
135.61M
Maximum
Feb 11 2021
15.55M
Average
4.846M
Median
Jan 25 2024
Enterprise Value Benchmarks
| CEL-SCI Corp | 36.25M |
| AIM ImmunoTech Inc | 8.915M |
| IGC Pharma Inc | 26.16M |
| NovaBay Pharmaceuticals Inc | 2.608M |
| Protalix BioTherapeutics Inc | 97.03M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.549M |
| Revenue (Quarterly) | 0.03M |
| Total Expenses (Quarterly) | 2.638M |
| EPS Diluted (Quarterly) | -0.14 |
| Gross Profit Margin (Quarterly) | 96.67% |
| Profit Margin (Quarterly) | -8.50K% |
| Earnings Yield | -265.0% |
| Normalized Earnings Yield | -265.00 |